Re: Shrinking MACE event rate
in response to
by
posted on
Jan 19, 2019 06:33PM
What I mean is that the FDA has accepted that there's a path forward to approval for Apabetalone if BETonMACE succeeds as constructed...that news came out in June if memory serves, at a time when there was still some speculation about the possibility of expanding the trial.
And they're going past 250 events as I was just reminded by the most recent Zacks report from the end of November.